SLW Institute

SLW Institute

Looking for educational content on intellectual property? The Schwegman firm has developed the SLW Institute, aimed to deliver educational and training content in a variety of ways for you to advance your IP knowledge.

Webinar New! On Demand

Emerging Tech Series

01/27/2022

Emerging Tech

CleanTech: Follow the Money and the Patents

Foreign Patent Firms Can Now Open Representative Offices in China

Shanghai’s No. 3 Intermediate Court Sentences DuPont Counterfeiter to 2+ Years in Prison

Novartis v. Accord – No Limits on Negative Limitations?

Chinese Invention Patent and Utility Model Grants Both Up 31% in 2021

Guest Post: Tackling Bad Faith Trademark Applications or Registrations in China – Part II

Vanillin Trade Secret Case Makes 2021 Top Ten Chinese People’s Court Cases

China Issues 115 Point Outline for Building a Powerful Intellectual Property Country

CNIPA’s draft Patent Examination Guidelines – what is coming down the pipeline?

Biogen v. Mylan – Therapeutic v. Clinical Efficacy – What is Required by the Written Description Requirement?

China Revokes Patent Firm Licenses for Filing Irregular Patent Applications

Schwegman Lundberg & Woessner

Schwegman Lundberg & Woessner

Filter Resources

Resources By Type

Resources By Topic

CleanTech: Follow the Money and the Patents

Foreign Patent Firms Can Now Open Representative Offices in China

Shanghai’s No. 3 Intermediate Court Sentences DuPont Counterfeiter to 2+ Years in Prison

Novartis v. Accord – No Limits on Negative Limitations?

Chinese Invention Patent and Utility Model Grants Both Up 31% in 2021

Guest Post: Tackling Bad Faith Trademark Applications or Registrations in China – Part II

Vanillin Trade Secret Case Makes 2021 Top Ten Chinese People’s Court Cases

China Issues 115 Point Outline for Building a Powerful Intellectual Property Country

CNIPA’s draft Patent Examination Guidelines – what is coming down the pipeline?

Biogen v. Mylan – Therapeutic v. Clinical Efficacy – What is Required by the Written Description Requirement?

China Revokes Patent Firm Licenses for Filing Irregular Patent Applications

Non-Prosecution Agreement Announced in Underwriters Laboratories (UL) Chinese Criminal Copyright Case

Schwegman Lundberg & Woessner

SLW Institute

Filter Resources

Resources By Type

Resources By Topic

Subscribe

CleanTech: Follow the Money and the Patents

Foreign Patent Firms Can Now Open Representative Offices in China

Shanghai’s No. 3 Intermediate Court Sentences DuPont Counterfeiter to 2+ Years in Prison

Novartis v. Accord – No Limits on Negative Limitations?

Chinese Invention Patent and Utility Model Grants Both Up 31% in 2021

Guest Post: Tackling Bad Faith Trademark Applications or Registrations in China – Part II

Vanillin Trade Secret Case Makes 2021 Top Ten Chinese People’s Court Cases

China Issues 115 Point Outline for Building a Powerful Intellectual Property Country

CNIPA’s draft Patent Examination Guidelines – what is coming down the pipeline?

Biogen v. Mylan – Therapeutic v. Clinical Efficacy – What is Required by the Written Description Requirement?

China Revokes Patent Firm Licenses for Filing Irregular Patent Applications

Non-Prosecution Agreement Announced in Underwriters Laboratories (UL) Chinese Criminal Copyright Case